Cancer Research KI
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, that includes some 350 research groups. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
Sign-up to our Newsletter & Mailing List
Previous Newsletters
Researcher Profiles
SAVE THE DATE : En dag för cancerforskning, Karolinska Institutet 16th November 2022
En dag för cancerforskning, Karolinska Institutet
En dag för cancerforskning, Karolinska Institutet
SAVE THE DATE: den 16 november 2022!
"En dag för cancerforskning, Karolinska Institutet" går av stapeln den 16 november 2022.
Under dagen samlades forskare och för att berätta om den banbrytande cancerforskning de arbetar med. Kolla in programmet från förra året och håll utkik för mer information.
En anmälan öppnar i augusti!
Cancer Research KI News
2022 KI- Mayo Collaborative grant recipients
2022 KI- Mayo Collaborative grant recipients
The Mayo Clinic Cancer Center and Cancer Research K are pleased to announce the 2022 recipients of the collaborative grants supporting Breast Cancer, other Solid Tumors, and Hematologic Malignancies research.
Cancer Research KI aims to increase your visibility to attract internal, international, industrial collaborations and funding, and to add your group to the database of cancer research at KI
The database is intended for all principal investigators (PI) or team leaders engaged in some form of cancer research at KI.
Cancer Research KI performs different analyses to identify which cancer research domains might be missing or need more funding that can help us generate more funding opportunities for KI-based researchers. We are also approached by interested companies, PhD candidates, researchers, international collaborators and are directing them to specific research groups. It is our responsibility to represent you in the best way possible and provide the support that is needed. We need your help in providing all the information to get to know your cancer research group at KI.
Cancer Research KI awards the bridging grant at the consolidator level for a junior researcher
Cancer Research KI awards the bridging grant at the consolidator level for a junior researcher
The bridging grant provide two-year funding at the consolidator level to the highest ranked applicant who was not awarded the KI five-year consolidator grant (1.2 million SEK per year, for 2022-2023). The Bridging grant recipient is Linda Lindström, Associate Professor in Cancer Epidemiology and Group Leader at the Department of Oncology and Pathology.
Collaboration is the key to the future's cancer treatment
Collaboration is the key to the future's cancer treatment
Anna Martling (Precision Medicine Centre Karolinska (PMCK)) and Hans-Gustaf Ljunggren (NextGenNK) in an article in the Swedish newspapper Dagens Industri. Article in Swedish.
Kirsty Spalding and Bennie Lemmens granted with The Mark Foundation for Cancer Research ASPIRE Award
Kirsty Spalding and Bennie Lemmens granted with The Mark Foundation for Cancer Research ASPIRE Award
The Mark Foundation for Cancer Research granted two Karolinska Institutet’s principal investigators, Dr. Kirsty Spalding and Dr. Bennie Lemmens with ASPIRE (Accelerating Scientific Platform and Innovative Research) Awards. This is the first time that The Mark Foundation has awarded researchers from Sweden. They were selected as scientists who have an innovative approach to solving impactful problems in the cancer field.
Cancer Research KI maps cancer research principal investigators across KI
Cancer Research KI maps cancer research principal investigators across KI
Cancer Research KI has mapped the research landscape at KI and created a database with information about research groups across KI that conduct cancer research. The database is intended for researchers at KI and elsewhere as well as others interested in obtaining an overview of cancer research at KI, to foster new collaborations, learn more about specific cancer areas, or explore industrial interactions.
2021 Blue Sky grant recipients
2021 Blue Sky grant recipients
Congratulations to the Blue Sky grant recipients of 2021
2021 Translational seed funding grant recipients
2021 Translational seed funding grant recipients
Congratulations to all the Translational seed funding grant recipients of 2021.
Strengthened collaboration with Hungary in the field of cancer
Strengthened collaboration with Hungary in the field of cancer
Karolinska Comprehensive Cancer Center, new webpage
Karolinska Comprehensive Cancer Center, new webpage
Karolinska CCC brings together cutting-edge expertise in highly specialized cancer care and basic, translational, and clinical cancer research. Read more about the organisation on their new webpage.
6th Cancer Swedish Research Meeting 16-17th May 2023
Save the date
Save the date
6th Swedish Cancer Research Meeting 16-17th of May 2023
The meeting is open to all clinical, preclinical researchers and others with an interest in cancer research from the organizing universities.
Venue: Karolinska Institutet, Aula Medica, Erling Persson-salen, Nobels väg 6, 171 65 Solna
Host: Cancer Research KI
Organizers: U-CAN from Uppsala/Umeå Universities, LUCC (Lund University Cancer Centre), University of Gothenburg, and Cancer Research KI from Karolinska Institutet.
Seminars and Workshops
Industry-academia collaborations, seminar series by Cancer Reseach KI
Industry-academia collaborations, seminar series by Cancer Reseach KI
The third seminar will be announced and registration will open after the summer break.
Welcome to the joint hybrid seminar between Cancer Research KI and Merck. During this seminar, you will learn how Merck is looking to expand their ongoing collaboration with KI in the areas of oncology and immuno-oncology. An ongoing project will also be presented. There will be time to discuss and ask questions during the afternoon. Please join either via zoom or in real life in Scheelesalen where fika will be served before the meeting.
Next Karolinska Clinical Cancer Talks with Associate Professor Mattias Rantalainen on 'AI-based precision pathology - cost-effective stratification of cancer patients at scale'
Next Karolinska Clinical Cancer Talks with Associate Professor Mattias Rantalainen on 'AI-based precision pathology - cost-effective stratification of cancer patients at scale'
30th May 2022 16.00-16.45, Rolf Luft L1:00 Solna or Teams
Please e-mail cancerresearchki@ki.se to get the teams link
Cancer Workshop for Patient Organisations 7th October, 2022
Cancer Workshop for Patient Organisations 7th October, 2022
In collaboration with RCC Stockholm-Gotland, Cancer Research KI, organises a digital workshop in cancer for patient organisations. The workshop is in Swedish and gives opportunities for interaction and communication between cancer patient organisations and researchers.
Grant Announcements
Collaborative Call: 2022 Karolinska Institutet and Mayo Clinic Cancer Center
Collaborative Call: 2022 Karolinska Institutet and Mayo Clinic Cancer Center
The Mayo Clinic Comprehensive Cancer Center and Karolinska Institutet are pleased to announce the 2022 Request for Applications (RFA) within the areas of breast cancer, other solid tumors, and hematologic malignancies with a submission deadline of April 1, 2022.